|
Profile Visibility  | | #1,775 in weekly profile views out of 24,595 lawyers in Washington, District of Columbia | | #60,152 in weekly profile views out of 968,464 total lawyers Overall |
|
|
| |
| Practice Areas | FDA and Healthcare; Public Policy and Legislative; Litigation | | | Education | Temple University, J.D., 1999, Howard University, B.A., cum laude, 1996 | | | Admitted | 1999, New Jersey; 2000, Pennsylvania; 2009, District of Columbia | |
| Memberships | American Bar Association. | | | Special Agencies | Food and Drug Administration. | | | Biography | Managing Editor, Temple Political and Civil Rights Law Review, 1998-1999. Associate, Pepper Hamilton LLP, 1999-2002. Associate Chief Counsel for Enforcement, Office of Chief Counsel, FDA, 2002-2008. FDA Commissioner's Award of Excellence, 2008. HHS, Secretary's Award for Distinguished Service, FDA Ephedra Rulemaking and Litigation, 2005. FDA Commissioner's Outstanding Service Award for Outstanding Legal Representation and Dedication in Conducting Enforcement and Defensive Litigation, 2005. Co-Author, "FDA's Evolving Civil Money Penalty Authority: Simple Violations Can Lead to Major Costs," GxP Lifeline Pharmaceutical, June 2009. Speaker: "Postmarket Requirements and Concerns for Medical Devices," American Conference Institute's FDA Boot Camp: Basic Training for Products Liability and Patent Lawyers, 2009; "Introduction to the US Drug Regulatory Process," Food and Drug Law Institute/Center for Drug Evaluation and Research / In-House Training, 2009; "Product Safety in North America: Emerging US Initiatives for Assuring Product Safety in the Era of Globalization," American Bar Association Section of International Law Spring Meeting, 2009. | | | ISLN | 914580773 | |
Documents by this lawyer on Martindale.com
The Food and Drug Administration's Focus on Online Marketing of Pharmaceutical ProductsDaniel A. Kracov, Vernessa T. Pollard, Joshua M. Glasser, April 30, 2009 On March 26, 2009, the US Food and Drug Administration's (FDA's) Division of Drug Marketing, Advertising, and Communications (DDMAC) sent Untitled Letters to 14 pharmaceutical companies addressing their use of "sponsored links" on internet search engines, i.e., links (with product-related... |
|
|